Kevin Daniels - Dec 31, 2023 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Role
CAO & Treasurer
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Stock symbol
CLB
Transactions as of
Dec 31, 2023
Transactions value $
-$48,901
Form type
4
Date filed
1/3/2024, 05:47 PM
Previous filing
Dec 4, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Stock Tax liability -$48.9K -2.77K -17.36% $17.66 13.2K Dec 31, 2023 Direct
transaction CLB Common Stock Options Exercise $0 +7.2K +82.3% $0.00 15.9K Dec 31, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Performance Shares Options Exercise $0 -7.2K -100% $0.00* 0 Dec 31, 2023 Common Stock 7.2K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on Decmeber 31, 2023 at the conclusion of the performance period.